185 related articles for article (PubMed ID: 3057041)
21. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis.
Ratner PH; Hampel F; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
Ann Allergy Asthma Immunol; 2008 Jan; 100(1):74-81. PubMed ID: 18254486
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the efficacy and tolerability of topically administered azelastine, sodium cromoglycate and placebo in the treatment of seasonal allergic conjunctivitis and rhino-conjunctivitis.
James IG; Campbell LM; Harrison JM; Fell PJ; Ellers-Lenz B; Petzold U
Curr Med Res Opin; 2003; 19(4):313-20. PubMed ID: 12841924
[TBL] [Abstract][Full Text] [Related]
23. Comparison of azelastine and chlorpheniramine in the treatment of mastocytosis.
Friedman BS; Santiago ML; Berkebile C; Metcalfe DD
J Allergy Clin Immunol; 1993 Oct; 92(4):520-6. PubMed ID: 8104966
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis.
van Bavel J; Howland WC; Amar NJ; Wheeler W; Sacks H
Allergy Asthma Proc; 2009; 30(5):512-8. PubMed ID: 19747429
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide.
Dorow P; Aurich R; Petzold U
Arzneimittelforschung; 1993 Aug; 43(8):909-12. PubMed ID: 8105785
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily.
Lumry W; Prenner B; Corren J; Wheeler W
Ann Allergy Asthma Immunol; 2007 Sep; 99(3):267-72. PubMed ID: 17910331
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis.
Shah S; Berger W; Lumry W; La Force C; Wheeler W; Sacks H
Allergy Asthma Proc; 2009; 30(6):628-33. PubMed ID: 19930788
[TBL] [Abstract][Full Text] [Related]
28. Effect of azelastine on the seasonal increase in non-specific bronchial responsiveness to methacholine in pollen allergic patients. A randomized, double-blind placebo-controlled, crossover study.
Balzano G; Gallo C; Masi C; Cocco G; Ferranti P; Melillo E; Seccia G
Clin Exp Allergy; 1992 Mar; 22(3):371-7. PubMed ID: 1350232
[TBL] [Abstract][Full Text] [Related]
29. A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis.
Herman D; Garay R; Le Gal M
Int J Pediatr Otorhinolaryngol; 1997 Feb; 39(1):1-8. PubMed ID: 9051434
[TBL] [Abstract][Full Text] [Related]
30. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety.
Meltzer EO; LaForce C; Ratner P; Price D; Ginsberg D; Carr W
Allergy Asthma Proc; 2012; 33(4):324-32. PubMed ID: 22856633
[TBL] [Abstract][Full Text] [Related]
31. Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine.
Stern MA; Wade AG; Ridout SM; Cambell LM
Ann Allergy Asthma Immunol; 1998 Oct; 81(4):354-8. PubMed ID: 9809500
[TBL] [Abstract][Full Text] [Related]
32. Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic rhinitis in response to grass pollens.
Pelucchi A; Chiapparino A; Mastropasqua B; Marazzini L; Hernandez A; Foresi A
J Allergy Clin Immunol; 1995 Feb; 95(2):515-23. PubMed ID: 7852667
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
Wober W; Diez Crespo CD; Bähre M
Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
[TBL] [Abstract][Full Text] [Related]
34. Sequential therapy with azelastine in seasonal allergic rhinitis. Deutsche Rhinitis Studiengruppe (German Rhinitis Study Group).
Kremer B; Klimek L; Gülicher D; Degen M; Mösges R
Arzneimittelforschung; 1999 Nov; 49(11):912-9. PubMed ID: 10604044
[TBL] [Abstract][Full Text] [Related]
35. Double-blind assessment of azelastine in the treatment of perennial allergic rhinitis.
Grossman J; Halverson PC; Meltzer EO; Shoenwetter WF; van Bavel JH; Woehler TR; Freitag JJ; Hemsworth GR
Ann Allergy; 1994 Aug; 73(2):141-6. PubMed ID: 8067597
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen.
Howland WC; Amar NJ; Wheeler W; Sacks H
Int Forum Allergy Rhinol; 2011; 1(4):275-9. PubMed ID: 22287431
[TBL] [Abstract][Full Text] [Related]
37. Addition of ibuprofen to pseudoephedrine and chlorpheniramine in the treatment of seasonal allergic rhinitis.
Meltzer EO; Berman GD; Corren J; Pedinoff AJ; Doyle G; Waksman JA; Butkerait P; Cooper SA; Berlin RG; Wason S
Ann Allergy Asthma Immunol; 2004 Nov; 93(5):452-9. PubMed ID: 15562884
[TBL] [Abstract][Full Text] [Related]
38. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device.
Hampel FC; Ratner PH; Van Bavel J; Amar NJ; Daftary P; Wheeler W; Sacks H
Ann Allergy Asthma Immunol; 2010 Aug; 105(2):168-73. PubMed ID: 20674829
[TBL] [Abstract][Full Text] [Related]
39. Single-patient drug trial methodology for allergic rhinitis.
Reitberg DP; Del Rio E; Weiss SL; Rebell G; Zaias N
Ann Pharmacother; 2002 Sep; 36(9):1366-74. PubMed ID: 12196053
[TBL] [Abstract][Full Text] [Related]
40. Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitis.
Bernstein JA; Prenner B; Ferguson BJ; Portnoy J; Wheeler WJ; Sacks HJ
Am J Rhinol Allergy; 2009; 23(5):512-7. PubMed ID: 19807985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
